Alzheimer's Disease
1,115
58
75
745
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
296 trials with published results (27%)
Research Maturity
745 completed trials (67% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.2%
136 terminated out of 1115 trials
84.6%
-1.9% vs benchmark
18%
196 trials in Phase 3/4
40%
296 of 745 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 745 completed trials
Clinical Trials (1115)
A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Functional Magnetic Resonance Imaging - Synthetic Aperture Magnetometry (fMRI-SAM) and Alzheimer's Disease
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)
Pathological and Non-pathological Aging, Physical Activity, Genotype and Cognition
Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 2
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
TREAD: Time Restricted Eating Intervention for Alzheimer's Disease
Tango for Alzheimer's Disease Patients' Caregivers
Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease
A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)
Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenous ABBV-1758 Moves Through the Body of Adult Participants With Alzheimer's Disease
BAC in Patient With Alzheimer's Disease or Vascular Dementia
Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment
A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD)